Literature DB >> 7954762

Octreotide dependency and headache: a case report.

A May1, S Lederbogen, H C Diener.   

Abstract

We report on headache induced by a somatostatin octapeptide analog (octreotide) used for the treatment of acromegaly. This "rebound" headache has severe tension-type characteristics and occurs every 6-8 h. It resolves dramatically within minutes with octreotide administration. This is the first report of headache developing under treatment with octreotide.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7954762     DOI： 10.1046/j.1468-2982.1994.1404303.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


  6 in total

1.  The association of pituitary tumors and headache.

Authors:  Miles J Levy
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

2.  Somatotropinoma infarction during octreotide therapy leading to bilateral cavernous sinus syndrome.

Authors:  N M Boulis; A J Noordmans; A Barkan; J Hassing; W F Chandler
Journal:  Pituitary       Date:  2000-11       Impact factor: 4.107

Review 3.  Treatment of pituitary tumors: somatostatin.

Authors:  Maria A Tichomirowa; Adrian F Daly; Albert Beckers
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

Review 4.  Clinical Presentation and Management of Headache in Pituitary Tumors.

Authors:  Himanshu Suri; Carrie Dougherty
Journal:  Curr Pain Headache Rep       Date:  2018-06-15

5.  Adverse drug reaction reporting by patients in the Netherlands: three years of experience.

Authors:  Joyce de Langen; Florence van Hunsel; Anneke Passier; Lolkje de Jong-van den Berg; Kees van Grootheest
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 6.  Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.

Authors:  Alin Abreu; Alejandro Pinzón Tovar; Rafael Castellanos; Alex Valenzuela; Claudia Milena Gómez Giraldo; Alejandro Castellanos Pinedo; Doly Pantoja Guerrero; Carlos Alfonso Builes Barrera; Humberto Ignacio Franco; Antônio Ribeiro-Oliveira; Lucio Vilar; Raquel S Jallad; Felipe Gaia Duarte; Mônica Gadelha; Cesar Luiz Boguszewski; Julio Abucham; Luciana A Naves; Nina Rosa C Musolino; Maria Estela Justamante de Faria; Ciliana Rossato; Marcello D Bronstein
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.